Hvivo
Organization
A specialist clinical-services company conducting human challenge trials and related research for vaccines, antivirals, and infectious-disease treatments.
What experts have said about Hvivo
2 statements · 2 positive
Hvivo is viewed favorably as an investment.
“we do like that one”
Open the episode · Paul's Podcast - Fri 8 May 2026Listen at 16:32
Hvivo reported very strong results and favorable contract news.
“They came out with results which were very strong. Good contract news.”
Open the episode · IC033 Stonking Small Caps Release Good Results & Potential Tax ChangesListen at 7:05
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
3 episodes featuring Hvivo
The Sunday Roast
Mining deals and biotech catalysts shape a midsummer market review
The episode tests how financing, clinical evidence, national resilience and exploration milestones could reshape several small-cap stories through 2026.
Aug 2, 2026 · 1h 45m
UK Small/Mid Caps with Paul Scott
Paul Scott revisits a disputed Novacyte market move
The episode shows how quickly a stock-market discussion can turn on correcting a single reported figure.
May 8, 2026 · 36 min
Investor's Champion Podcast
Small-cap investors weigh tax fears against execution
The discussion tests whether recent weakness creates opportunity or exposes businesses that still lack cash generation, clarity, and disciplined growth.
Sep 15, 2024 · 32 min